HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factors affecting the likelihood of monkeypox's emergence and spread in the post-smallpox era.

Abstract
In 1980, the World Health Assembly announced that smallpox had been successfully eradicated as a disease of humans. The disease clinically and immunologically most similar to smallpox is monkeypox, a zoonosis endemic to moist forested regions in West and Central Africa. Smallpox vaccine provided protection against both infections. Monkeypox virus is a less efficient human pathogen than the agent of smallpox, but absent smallpox and the population-wide immunity engendered during eradication efforts, could monkeypox now gain a foothold in human communities? We discuss possible ecologic and epidemiologic limitations that could impede monkeypox's emergence as a significant pathogen of humans, and evaluate whether genetic constrains are sufficient to diminish monkeypox virus' capacity for enhanced specificity as a parasite of humans.
AuthorsMary G Reynolds, Darin S Carroll, Kevin L Karem
JournalCurrent opinion in virology (Curr Opin Virol) Vol. 2 Issue 3 Pg. 335-43 (Jun 2012) ISSN: 1879-6265 [Electronic] Netherlands
PMID22709519 (Publication Type: Journal Article, Review)
CopyrightPublished by Elsevier B.V.
Topics
  • Africa, Central (epidemiology)
  • Africa, Western (epidemiology)
  • Animals
  • Ecosystem
  • Humans
  • Monkeypox (epidemiology, prevention & control, transmission)
  • Monkeypox virus (immunology, pathogenicity)
  • Risk Assessment
  • Zoonoses (transmission)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: